Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats.

Sharma AK, Khanna D, Balakumar P.

Int J Cardiol. 2014 Mar 15;172(2):530-2. doi: 10.1016/j.ijcard.2014.01.053. Epub 2014 Jan 23. No abstract available.

PMID:
24495652
2.

Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.

Bhardwaj P, Khanna D, Balakumar P.

Cardiovasc Toxicol. 2014 Mar;14(1):41-51. doi: 10.1007/s12012-013-9226-y.

PMID:
24048981
3.

Mechanism of attenuation of diabetes mellitus and hypercholesterolemia induced vascular endothelial dysfunction by protein tyrosine phosphatase inhibition.

Sharma S, Singh M, Sharma PL.

Vascul Pharmacol. 2011 Mar-Jun;54(3-6):80-7. doi: 10.1016/j.vph.2010.12.005. Epub 2011 Jan 13.

PMID:
21237289
4.

[Inhibition of induced thrombocyte aggregation in the presence of endothelial cells by dipyridamole].

Kirchmaier CM, Altorjay J, Bellinger O, Breddin HK.

Vasa Suppl. 1991;32:318-21. German.

PMID:
1771524
5.

Vascular and renal effects of vasopeptidase inhibition and angiotensin-converting enzyme blockade in spontaneously diabetic Goto-Kakizaki rats.

Cheng ZJ, Grönholm T, Louhelainen M, Finckenberg P, Merasto S, Tikkanen I, Mervaala E.

J Hypertens. 2005 Sep;23(9):1757-70.

PMID:
16093923
6.

Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas.

Wang LJ, Yu YH, Zhang LG, Wang Y, Niu N, Li Q, Guo LM.

Eur J Pharmacol. 2008 Nov 12;597(1-3):75-80. doi: 10.1016/j.ejphar.2008.08.031. Epub 2008 Sep 3.

PMID:
18796303
7.

The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.

De La Cruz JP, Moreno A, Mérida F, García Campos J, Sánchez de la Cuesta F.

Thromb Res. 1996 Feb 1;81(3):327-37.

PMID:
8928090
8.
10.

Eplerenone improves vascular function and reduces platelet activation in diabetic rats.

Schafer A, Vogt C, Fraccarollo D, Widder J, Flierl U, Hildemann SK, Ertl G, Bauersachs J.

J Physiol Pharmacol. 2010 Feb;61(1):45-52.

11.

Sesamin exerts renoprotective effects by enhancing NO bioactivity in renovascular hypertensive rats fed with high-fat-sucrose diet.

Wu XQ, Kong X, Zhou Y, Huang K, Yang JR, Li XL.

Eur J Pharmacol. 2012 May 15;683(1-3):231-7. doi: 10.1016/j.ejphar.2012.01.029. Epub 2012 Feb 1.

PMID:
22314221
12.
14.

Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.

De la Cruz JP, Moreno A, Muñoz M, García Campos JM, Sánchez de la Cuesta F.

J Pharmacol Exp Ther. 1997 Jan;280(1):454-9.

15.
16.

[Endothelium and platelets in pregnant women with chronic glomerulonephritis and therapeutic efficacy of acetylsalicylic acid and dipiridamol].

Rogov VA, Shilov EM, Kozlovskaia NL, Gordovskaia NB, Sidorova IS, Krylova MIu, Artem'eva VB.

Ter Arkh. 2004;76(12):58-64. Russian.

PMID:
15724929
17.

Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.

Wang C, Li J, Lv X, Zhang M, Song Y, Chen L, Liu Y.

Eur J Pharmacol. 2009 Oct 12;620(1-3):131-7. doi: 10.1016/j.ejphar.2009.07.027. Epub 2009 Aug 15.

PMID:
19686728
18.

Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.

Heidarianpour A, Hajizadeh S, Khoshbaten A, Niaki AG, Bigdili MR, Pourkhalili K.

Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):746-52.

PMID:
18043294
19.

Diabetic eNOS knockout mice develop distinct macro- and microvascular complications.

Mohan S, Reddick RL, Musi N, Horn DA, Yan B, Prihoda TJ, Natarajan M, Abboud-Werner SL.

Lab Invest. 2008 May;88(5):515-28. doi: 10.1038/labinvest.2008.23. Epub 2008 Apr 7.

20.

Supplemental Content

Support Center